(+/-)-Endo-5-Hexyl-4-phenyl-3a-(1-phenylvinyl)-1,2,3,3a,6,6a-hexahydropentalen-1-yl Sulfamide

ID: ALA4440757

Chembl Id: CHEMBL4440757

PubChem CID: 138857912

Max Phase: Preclinical

Molecular Formula: C28H36N2O2S

Molecular Weight: 464.68

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C(c1ccccc1)[C@@]12CC[C@H](NS(N)(=O)=O)[C@@H]1CC(CCCCCC)=C2c1ccccc1

Standard InChI:  InChI=1S/C28H36N2O2S/c1-3-4-5-8-17-24-20-25-26(30-33(29,31)32)18-19-28(25,21(2)22-13-9-6-10-14-22)27(24)23-15-11-7-12-16-23/h6-7,9-16,25-26,30H,2-5,8,17-20H2,1H3,(H2,29,31,32)/t25-,26-,28-/m0/s1

Standard InChI Key:  COQCBADNBTZWQG-NSVAZKTRSA-N

Alternative Forms

  1. Parent:

    ALA4440757

    ---

Associated Targets(Human)

NR5A2 Tchem Orphan nuclear receptor LRH-1 (736 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR5A1 Tchem Steroidogenic factor 1 (399 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 464.68Molecular Weight (Monoisotopic): 464.2497AlogP: 6.09#Rotatable Bonds: 10
Polar Surface Area: 72.19Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 10.87CX Basic pKa: CX LogP: 5.80CX LogD: 5.80
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.42Np Likeness Score: 0.35

References

1. Mays SG, Flynn AR, Cornelison JL, Okafor CD, Wang H, Wang G, Huang X, Donaldson HN, Millings EJ, Polavarapu R, Moore DD, Calvert JW, Jui NT, Ortlund EA..  (2019)  Development of the First Low Nanomolar Liver Receptor Homolog-1 Agonist through Structure-guided Design.,  62  (24): [PMID:31419141] [10.1021/acs.jmedchem.9b00753]
2. Cornelison JL, Cato ML, Johnson AM, D'Agostino EH, Melchers D, Patel AB, Mays SG, Houtman R, Ortlund EA, Jui NT..  (2020)  Development of a new class of liver receptor homolog-1 (LRH-1) agonists by photoredox conjugate addition.,  30  (16): [PMID:32631515] [10.1016/j.bmcl.2020.127293]

Source